[Synthetic studies of microbial natural products from microorganisms].
Sunazuka
Toshiaki
T
D000111:Acetylcysteine / Q000031:analogs & derivatives* / Q000138:chemical synthesis; D000818:Animals; D000900:Anti-Bacterial Agents / Q000138:chemical synthesis / Q000494:pharmacology; D019086:Bridged Bicyclo Compounds, Heterocyclic / Q000138:chemical synthesis; D002800:Cholinesterase Inhibitors / Q000138:chemical synthesis; D015195:Drug Design; D005765:Gastrointestinal Agents; D006571:Heterocyclic Compounds / Q000138:chemical synthesis; D006801:Humans; D007211:Indoles / Q000138:chemical synthesis; D018942:Macrolides; D009037:Motilin / Q000819:agonists; D010528:Peristalsis / Q000187:drug effects; D011714:Pyrans / Q000138:chemical synthesis; D011725:Pyridines / Q000138:chemical synthesis; D012717:Sesquiterpenes / Q000138:chemical synthesis; D002785:Sterol O-Acyltransferase / Q000037:antagonists & inhibitors; D013329:Structure-Activity Relationship
D000900:Anti-Bacterial Agents; D019086:Bridged Bicyclo Compounds, Heterocyclic; D002800:Cholinesterase Inhibitors; D005765:Gastrointestinal Agents; D006571:Heterocyclic Compounds; D007211:Indoles; D018942:Macrolides; D011714:Pyrans; D011725:Pyridines; D012717:Sesquiterpenes; C095353:arisugacin; C097798:macrosphelide A; C103158:madindoline A; C048222:paspalicine; C067713:lactacystin; C082792:pyripyropene A; D009037:Motilin; D002785:Sterol O-Acyltransferase; D000111:Acetylcysteine